Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Noveome Biotherapeutics announced it raised $6.75 Million in an initial filing from an offering of $15 Million
PRIVATEAug 27, 2026•about 3 hours ago
Amount Raised
$6.75 Million
Round Type
Venture - Series Unknown
PittsburghBiotechnology
Company Information
Company
Noveome Biotherapeutics
Location
100 TECHNOLOGY DRIVE
Pittsburgh, Pennsylvania, United States
About
Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development.
Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules directed at specific indications, Noveome’s product is a complex mixture of biomolecules that is believed to have the ability to treat a wide range of conditions and injuries. Noveome collaborates with major research centers to advance these therapeutic applications.
Don't miss Noveome Biotherapeutics's next move
Get an email the moment Noveome Biotherapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contacts12 people are listed at Noveome Biotherapeutics. We don't have their email yet.
Predictive Intelligence
Strategic
ML-powered predictions for Noveome Biotherapeutics's next move
PittsburghBiotechnology